Reduced heparan sulfate levels in cerebrospinal fluid reflect brain neuron correction in Sanfilippo B mice
Le, S. Q.; Sorensen, A.; Sukupolvi, S.; Jewhurst, G.; Austin, G.; Doray, B.; Cooper, J. D.; Dickson, P.
Show abstract
Sanfilippo B syndrome is a rare, inherited disorder of heparan sulfate catabolism. Cerebrospinal fluid heparan sulfate (HS) has been pursued as a biomarker for CNS disease. To determine whether CSF HS reflects disease in the brain, we generated a fusion protein of the NAGLU gene encoding alpha-N-acetylglucosaminidase (the enzyme deficient in Sanfilippo B) and the transmembrane region and cytosolic tail of LAMP1, which encodes the lysosomal-associated membrane protein-1, to tether the NAGLU enzyme to the membrane and prevent cross-correction. We used AAV7 to deliver the fusion construct intravenously to Sanfilippo B mice and showed that treatment of systemic bodily organs without treatment of brain did not result in reduction of CSF HS compared with untreated Sanfilippo B mice. Next, we used intracerebroventricular delivery of the construct in AAV9 under a synapsin-1 promotor to largely confine expression to brain neurons. We showed that treatment of the brain without treatment of systemic bodily organs resulted in reduction of HS in brain and CSF. These results support the utility of CSF HS as a therapeutic biomarker for Sanfilippo B and other disorders of heparan sulfate catabolism.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Antisense therapy in a new rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment. 92%
- A cell-penetrant peptide blocking C9ORF72-repeat RNA nuclear export suppresses neurodegeneration 92%
- Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis 91%
Similar papers in this journal
Similar papers in this journal
- Hematopoietic stem cell gene therapy improves outcomes in a clinically relevant mousemodel of Multiple Sulfatase Deficiency 93%
- AAV-mediated gene therapy for Sialidosis 93%
- Preclinical lentiviral vector-mediated hematopoietic stem and progenitor cell gene therapy corrects Pompe disease-related muscle and neurological manifestations 92%
Similar papers in this journal
- An antisense oligonucleotide-based strategy to ameliorate cognitive dysfunction in the 22q11.2 Deletion Syndrome 91%
- Exploring therapeutic strategies for Infantile Neuronal Axonal Dystrophy (INAD/PARK14) 91%
- Cell autonomous role of leucine-rich repeat kinase in protection of dopaminergic neuron survival 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.